App-Quantinova.ai

Use of levothyroxine for euthyroid women with positive thyroid antibodies and infertility: Results of thesis (treatment of hypothyroidism in europe by specialists: an international survey)

Roberto Negro - European Thyroid Association (ETA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Hypothyroidism

Levothyroxine

The optimal ranges of thyroid function based on the risk of cardiovascular disease and mortality: an individual participant data meta-analysis

Yanning Xu - European Thyroid Association (ETA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Resistance to thyroid hormone alpha: molecular, biochemical and physiological approach to diagnosis and therapy

Maura Agostini - European Thyroid Association (ETA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Thyroid hormone resistance syndrome

N/A

Study of target tissue-resident immune cells in graves’ disease and orbitopathy (star-GO): preliminary findings with a novel extensive immunophenotyping panel

Sara Maioli - European Thyroid Association (ETA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Autoimmune Thyroid Disease

Thyrotropin alfa

Characteristics of specialists delivering clinical care for hypothyroidism in eupope: the “THESIS” study (treatment of hypothyroidism in europe by specialists: an international survey)

Milos Zarkovic - European Thyroid Association (ETA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypothyroidism

N/A

The dawning of deiodinases: an outer ring deiodinase activity in the social amoeba dictyostelium discoideum with high affinity for reverse t3

Marcel Meima - European Thyroid Association (ETA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

The sollid study (simplification of low level internal dosimetry): preliminary findings

Stephen Hyer - European Thyroid Association (ETA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Treatment of hypothyroidism in europe by specialists: an international survey (THESIS): analysis of contested indications for prescribing among uk participants

Younes R Younes - European Thyroid Association (ETA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypothyroidism

N/A

Molecular mechanisms underlying action of triac in resistance to thyroid hormone BETA (RTHβ)

Wenjun Liao - European Thyroid Association (ETA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Thyroid hormone resistance syndrome

N/A

The incidence and risk factors of radioiodine-induced graves’ disease following treatment of thyroid autonomous tissue

Tjasa Zaletel - European Thyroid Association (ETA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

I-123

European thyroid association guideline on the management of pediatric thyroid nodules and thyroid carcinoma

Chantal A. Lebbink - European Thyroid Association (ETA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Thyroid Cancer

N/A

Patient-reported outcomes (PROS) from patients with RET-mutant medullary thyroid cancer (MTC) and ret fusion-positive TC treated with pralsetinib in the arrow trial

Julien Hadoux - European Thyroid Association (ETA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Thyroid Cancer

Cabozantinib

Associations Between Multimorbidity At Stroke/transient Ischaemic Attack Onset With All-cause Mortality Are Not Explained By Blood Biomarkers A Population-based Study

Matthew B Downer - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Transient Ischemic Attack

Fibrinogen (IV)

Derivation And Validation Of The SAVED2 Score For Prediction Of Unfavorable Modified Rankin Scale Score Following Intracerebral Hemorrhage

Craig I Coleman - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Intracerebral hemorrhage

N/A

Comparative Outcome Of Patients With And Without Mild Pre-Stroke Morbidity Following Endovascular Treatment - Results From The Hermes Meta-analysis

Rosalie V McDonough - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Vagus Nerve Stimulation Paired With Rehabilitation For Upper Limb Motor Function After Ischaemic Stroke Sub-group Analysis Of The Randomised, Blinded, Pivotal, Vns-Rehab Device Trial.

Jesse Dawson - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

CT Perfusion For Lesion-Symptom Mapping In Emergent Large Vessel Occlusion

Ain A Neuhaus - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Functional Outcome Of Patients 85 Years Or Older With Acute Ischemic Stroke Following Endovascular Treatment - A Substudy Of The Hermes Meta-analysis

Rosalie V McDonough - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Assessment Of MR Blood-Oxygen-Level-Dependent Cerebrovascular Reactivity Under General Anaesthesia In Children With Moyamoya

Eun Jung Choi - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Sex-specific Genome Wide Association Study Of Early-onset Ischemic Stroke

Liisa Tomppo - International Stroke Conference (ISC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Filters

45280 Abstracts